// App-Quantinova.ai

: Results from the ITP World IMPACT Survey (I-WISh): Patients with Immune Thrombocytopenia (ITP) Experience Impaired Quality of Life (QoL) Regarding Daily Activities, Social Interactions, Emotional Well-Being and Working Lives

Researchers

Presenter

  • Nichola Cooper

Principal Investigators

  • Alexandra Kruse

  • Caroline Kruse

  • Shirley Watson

  • Mervyn Morgan

  • James B. Bussel

  • Waleed Ghanima

  • Donald M. Arnold

  • Cristina Santoro

  • Ming Hou

  • Yoshiaki Tomiyama

  • Serge Laborde

  • Barbara Lovrencic

  • John Waller

  • Tom Bailey

  • Gavin Taylor-Stokes

  • Miona Stankovic

  • Andrew Provan

Medical Centers

  • Hammersmith Hospital, Imperial College, London, United Kingdom

  • Platelet Disorder Support Association, Cleveland

  • ITP Support Association,Bedfordshire,United Kingdom

  • Division of Hematology & Medical Oncology, Weill Cornell Medical College, New York, NY

  • Department of Medicine, Vestfold Hospital Trust, Tønsberg, Norway

  • Department of Medicine, McMaster University, Hamilton, ON, Canada

  • Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy

  • Department of Hematology, Shandong University, Qilu Hospital, Jinan, China

  • Osaka University Hospital, Suita, Japan

  • O'Cyto, Saint Loubes, France

  • Italian Association Immune Thrombocytopenic Purpura,Caprino Veronese,Italy

  • Bespoke Team,Adelphi Real World,Macclesfield,United Kingdom

  • Novartis AG, Basel, Switzerland

  • Barts and the London School of Medicine, London, United Kingdom

Locations

  • United Kingdom

  • United States

  • Norway

  • Canada

  • Italy

  • China

  • Japan

  • France

  • Switzerland

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Immune thrombocytopenia

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • Cross-Sectional

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved